Understanding Hypergastrinemia: A Complete Guide to High Gastrin Levels
Updated: 2 days ago
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026
Quick Answer
Hypergastrinemia is a condition marked by higher-than-normal levels of gastrin, the hormone that signals the stomach to release acid for digestion. Common causes include long-term use of PPIs or antacids, H. pylori infection and chronic atrophic gastritis. Symptoms include abdominal pain, chronic diarrhea and stomach ulcers, and long-term untreated cases may lead to gastric carcinoids or other tumors. [1]
What the research says
Higher gastrin levels were linked to a higher risk of stomach cancer. In a Norwegian population study that matched 181 people who later developed gastric adenocarcinoma with 359 controls, prediagnostic hypergastrinemia (above 60 pmol/L) was associated with more than double the odds of gastric adenocarcinoma overall (OR 2.2, 95% CI 1.4-3.4) and about six times the odds for tumors in the upper (proximal) stomach (OR 6.1, 95% CI 2.7-13.8). This shows an association, not proof that gastrin causes the cancer. (Ness-Jensen et al., International Journal of Cancer, 2021)
Gastrin rose with long-term acid suppression, but a 5-year trial found no malignant changes. In a randomized trial of 202 Japanese patients with healed erosive esophagitis, median serum gastrin after 260 weeks was 200 pg/mL on the PPI lansoprazole and 625 pg/mL on the stronger acid blocker vonoprazan. No malignant changes or gastric neuroendocrine tumors were seen in either group. (Uemura et al., Clinical Gastroenterology and Hepatology, 2025)
Gastrin rises in everyone on long-term PPIs, and long-term data are limited. An NIH-led review notes that chronic hypergastrinemia occurs in all patients taking chronic PPIs, that most safety studies lasted under 5 years, and that little data exist beyond 10 years. Patients with Zollinger-Ellison syndrome, who take PPIs for life, serve as a model for these long-term effects. (Lee et al., International Journal of Molecular Sciences, 2019)
What is hypergastrinemia?

Hypergastrinemia occurs when levels of gastrin, a hormone that is vital for digestion, rise above the normal range. Gastrin is made by specialized cells called G cells, which sit in the lower part of the stomach lining near the small intestine. Its main job is to signal the stomach to release gastric acid, which breaks down food and helps the body absorb nutrients such as proteins and amino acids. [1]
The effect of hypergastrinemia is complex. It can lead to hyperchlorhydria (too much stomach acid) or hypochlorhydria (too little stomach acid), depending on your health history, previous surgeries, and the medicines you take. Because stomach acid is important for nutrient absorption and for protection against germs, any disruption in gastrin can affect overall digestive health. [1]
What are the common causes of hypergastrinemia?

Causes are usually grouped by how they affect stomach acid. Finding the specific trigger is essential for choosing the right treatment. [1]
Triggers for low and high stomach acid
Acid impact | Common causes |
Low acid (hypochlorhydria) | Long-term use of PPIs or antacids, H. pylori infection, chronic atrophic gastritis, kidney failure, colorectal (colon) cancer, and vagotomy (surgery on the vagus nerve). |
High acid (hyperchlorhydria) | Zollinger-Ellison syndrome (ZES), antral G-cell hyperplasia, Multiple Endocrine Neoplasia type 1 (MEN-1), gastric outlet obstruction, and retained antrum syndrome. |
The most frequent cause is long-term use of acid-reducing medicines such as PPIs for acid reflux or peptic ulcers. When acid is suppressed, the body responds by making more gastrin in an attempt to restore acid production. [2] Other serious causes include rare gastrin-producing tumors (gastrinomas) in Zollinger-Ellison syndrome, which drive the stomach to make large amounts of acid and can lead to severe ulcers. [1]
What are the symptoms and complications of hypergastrinemia?
Symptoms often reflect the underlying condition that is causing the hormone imbalance. The main signs are persistent abdominal pain, chronic diarrhea, and stomach ulcers. In severe cases, people can develop esophagitis, an inflammation of the esophagus caused by acid reflux. [1]
If left untreated, chronic hypergastrinemia can carry long-term risks. Researchers suspect that high gastrin may contribute to the growth of certain cancers, including blood cancers, esophageal cancer, and pancreatic cancer. Long-term hypergastrinemia may also lead to stomach tumors such as gastric carcinoids or gastric adenocarcinoma. [1] Type 1 gastric carcinoids, linked to chronic atrophic gastritis, are not likely to be cancerous. Type 2 gastric carcinoids, linked to ZES and MEN-1, are cancerous in about 7% to 12% of cases. [1]
How is hypergastrinemia diagnosed and managed?

To diagnose hypergastrinemia, healthcare providers measure gastrin in the blood and assess how much acid the stomach is making. You will be asked to fast beforehand and to stop taking a PPI for about a week before testing so the result is accurate. Never stop a PPI on your own; your doctor will tell you when and how to do it. Samples may be taken several times a day over several days to see whether your gastrin levels change. [1]
Diagnostic tools
Fasting gastrin test: A blood sample that shows whether gastrin levels are raised. [1]
Secretin stimulation test: Helps tell causes apart. A large rise in gastrin after a secretin infusion may point to Zollinger-Ellison syndrome. [1]
Stomach pH testing: Measures how acidic the stomach is. A pH below 2 may indicate Zollinger-Ellison syndrome. [1]
Treatment depends on the cause
PPI-related: Stopping the PPI usually reverses hypergastrinemia in five to seven days, but only do this under medical supervision. [1]
H. pylori infection or chronic atrophic gastritis: Antibiotics treat H. pylori infection; chronic atrophic gastritis is managed by treating its cause and regular monitoring. [1]
Colorectal cancer, gastric outlet obstruction, kidney disease, MEN-1, and ZES: Surgery that treats these conditions also treats the hypergastrinemia. [1]
Retained antrum syndrome: Removing the remaining lower stomach (antral) tissue can lower excess stomach acid. [1]
Conclusion
Hypergastrinemia is an important clinical marker that deserves careful investigation. Whether it comes from common medicines or from rare underlying diseases, managing it is key to preventing long-term problems such as ulcers and stomach tumors. With a proper diagnosis and a treatment plan aimed at the cause, most people can manage their gastrin levels and keep their digestive system healthy. [1]
Stay informed. For more information on digestive health and managing acid reflux, visit Rinnit.com.
Frequently Asked Questions
Can taking Tums cause hypergastrinemia?
Long-term, heavy use of antacids such as Tums can potentially raise gastrin levels as the body tries to compensate for the neutralized acid. If you rely on antacids often, talk to your doctor. [1]
Is hypergastrinemia a form of cancer?
No, it is a hormonal condition. However, if it goes untreated for a long time, it may increase the risk of certain tumors and cancers. [1]
How long does it take for gastrin levels to return to normal after stopping PPIs?
Stopping a PPI usually reverses hypergastrinemia in about five to seven days. [1] Do not stop a PPI without your doctor's advice, because your symptoms may return.
Can hypergastrinemia cause weight loss?
Not directly. However, the abdominal pain, diarrhea, and ulcers that can come with it may reduce how much you eat and lead to weight loss.
Is there a specific diet for hypergastrinemia?
Diet should focus on managing the underlying cause, such as avoiding trigger foods for acid reflux or following a kidney-friendly diet if kidney failure is the cause.
What is the difference between hyperchlorhydria and hypochlorhydria?
Hyperchlorhydria means too much stomach acid, while hypochlorhydria means too little. Hypergastrinemia can cause either. [1]
Are there any natural ways to lower gastrin?
The most effective way to lower gastrin is to treat the underlying medical cause. Healthy habits that ease acid reflux may reduce the need for PPIs, but speak with your doctor before changing any medicine.
Is Zollinger-Ellison syndrome common?
No. It is a rare condition involving gastrin-producing tumors, but it is one of the more serious causes of hypergastrinemia. [1]
Can children have hypergastrinemia?
Yes. It can affect anyone at any age, although it is more often diagnosed in adults, partly because of medication use. [1]
Does H. pylori always cause high gastrin?
H. pylori infection often causes inflammation that affects gastrin production, but the effect can vary from person to person. [1]
What are G cells?
G cells are specialized cells in the lower stomach lining that make gastrin and release it into the bloodstream. [1]
Can hypergastrinemia be prevented?
If you take antacids or PPIs long-term, talk to your doctor about how to manage the added risk and get regular checkups. [1]
Is chronic diarrhea always a symptom?
No, but it is common when high gastrin leads to excess stomach acid, which can irritate the intestines. [1]
What is a gastric carcinoid?
A gastric carcinoid is a slow-growing tumor in the stomach lining that can result from long-term high gastrin. Type 1 is rarely cancerous, while type 2 (linked to ZES and MEN-1) is cancerous in about 7% to 12% of cases. [1]
Should I be worried if my gastrin is slightly high?
A slightly raised level may not be a cause for concern, but it should be reviewed by a gastroenterologist to rule out an underlying problem.
Related Reading
Understanding Gastrin: The Engine of Digestive Health explains what the hormone gastrin does in digestion.
H. pylori Infection: The Stomach Germ Half the World Carries, Its Warning Signs, and How Antibiotics Clear It explains a common stomach infection that can raise gastrin levels.
Peptic Ulcer Disease: Causes, Symptoms, Diagnosis, and Treatment explains how stomach and duodenal ulcers form and are treated.
Gastrointestinal Neuroendocrine Tumors (GI NETs): Symptoms, Causes, Diagnosis, Treatment, and Outlook — What You Need to Know covers digestive tract tumors, including carcinoids linked to high gastrin.
References
Cleveland Clinic. Hypergastrinemia. Cleveland Clinic. Last updated June 8, 2022. https://my.clevelandclinic.org/health/diseases/23225-hypergastrinemia
Dacha S, Razvi M, Massaad J, et al. Hypergastrinemia. Gastroenterol Rep (Oxf). 2015;3(3):201-8. PMID 25698559. https://doi.org/10.1093/gastro/gov004
Ness-Jensen E, Bringeland EA, Mattsson F, et al. Hypergastrinemia is associated with an increased risk of gastric adenocarcinoma with proximal location: A prospective population-based nested case-control study. Int J Cancer. 2021;148(8):1879-1886. PMID 33091962. https://doi.org/10.1002/ijc.33354
Uemura N, Kinoshita Y, Haruma K, et al. Vonoprazan as a Long-term Maintenance Treatment for Erosive Esophagitis: VISION, a 5-Year, Randomized, Open-label Study. Clin Gastroenterol Hepatol. 2025;23(5):748-757.e5. PMID 39209187. https://doi.org/10.1016/j.cgh.2024.08.004
Lee L, Ramos-Alvarez I, Ito T, Jensen RT. Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome. Int J Mol Sci. 2019;20(20):5128. PMID 31623145. https://doi.org/10.3390/ijms20205128
This article is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have about a medical condition. Never disregard professional medical advice or delay seeking care because of something you have read here. If you think you may have a medical emergency, call your doctor or emergency services immediately.
Medical disclaimer
The information provided in this article is for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.




Comments